obesity drug news today glp-1 october 2025 Outlook for obesity in 2025: more than a transition year GLP-1 weight loss drugs, such

This article explores treatment duration, what happens when you stop, and factors influencing how long you may need GLP-1 therapy

Drugs like Semaglutide (Ozempic, Wegovy) and Liraglutide (Saxenda, Victoza) are not only changing the way we manage Type 2 Diabetes but also making waves in the weight-loss industry

Rats receiving vagotomy do not reduce food intake in response to peripherally injected GLP-1 indicating that vagal afferent nerves are needed to relay peripheral GLP-1 signals to higher brain regions to regulate feeding (Abbott et al., 2011)

Various guidelines have been proposed to mitigate the risk of adverse events, which includes avoiding initiation in those at extremes of age, recent history of DKA and frequent history of severe fungal infection [30]

Semaglutide Drugs BNF

It does not, on the evidence we have today, replace the injection for every patient